This study highlights the importance of alternative disease mechanisms in ADAD and sporadic AD, at least for the PSEN1 E280A mutation, that may be relevant to understand different pathogenic roles of amyloid pathology for regional brain atrophy and metabolic changes in early stages of ADAD and sporadic AD. The gene discussed is PSEN1; the disease is Brain atrophy.